A mobile health tool to improve antibiotic stewardship among village doctors in Bangladesh
移动医疗工具可改善孟加拉国乡村医生的抗生素管理
基本信息
- 批准号:10707328
- 负责人:
- 金额:$ 18.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-19 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract
Diarrheal diseases are the among the leading cause of death in children worldwide, most of which occur in
low- and middle-income countries (LMICs). The cornerstone for management of diarrhea is rehydration, though
antimicrobials are beneficial in some instances. Unfortunately, given that treatment is frequently empiric, based
mostly on clinical suspicion for bacterial causes, antimicrobials are overused in management of diarrheal
illness worldwide. Thus, there is a need for clinical decision support tools to inform clinical management and
promote antimicrobial stewardship. In particular, frontline healthcare providers in rural areas, such as village
doctors in Bangladesh, often have inadequate knowledge for the basis of antimicrobial use, and may benefit
greatly from guidance. We have recently developed a mobile phone based electronic clinical decision-support
tool (eCDST), and shown the impact of etiological prediction on physician antibiotic prescription practices for
pediatric diarrhea in two LMICs. In this proposal, our overarching goal is to customize our eCDST into a
comprehensive mHealth application (Accessible Diarrhea Etiology Prediction Tool, ADEPT) to support rural
health care providers in the management of pediatric diarrhea (R21 phase), and to measure its impact through
the performance of a pilot before-after feasibility study (R33 phase). Our work will contribute to an evidence
base for mHealth-enabled antimicrobial stewardship, with potential to extend beyond diarrheal illness, and into
other syndromes, including respiratory illness and febrile illness.
抽象的
腹泻疾病是全球儿童死亡的主要原因之一,其中大多数发生在
低收入和中等收入国家(LMIC)。腹泻管理的基石是补液,尽管
在某些情况下,抗菌剂是有益的。不幸的是,鉴于治疗经常是经验性的,基于
主要是关于细菌原因的临床怀疑,抗菌素在腹泻的治疗中被过度使用
全球疾病。因此,需要临床决策支持工具,以告知临床管理和
促进抗菌管理。特别是,农村地区的一线医疗保健提供者,例如村庄
孟加拉国的医生通常对抗菌使用的知识不足,并且可能受益
大大来自指导。我们最近开发了一个基于手机的电子临床决策支持
工具(ECDST),并显示了病因预测对医师抗生素处方实践的影响
两种LMIC的小儿腹泻。在此提案中,我们的总体目标是将我们的ECDST自定义为
全面的MHealth应用程序(可访问的腹泻病因预测工具,熟练)支持农村
儿科腹泻管理(R21阶段)的医疗保健提供者,并通过
试验前可行性研究(R33阶段)的表现。我们的工作将有助于证据
实现MHealth支持的抗菌药物的基础,有可能超越腹泻病,并进入
其他综合症,包括呼吸道疾病和高热疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Ashraful Islam Khan其他文献
Coverage and acceptability of cholera vaccine among high-risk population of urban Dhaka, Bangladesh
- DOI:10.1016/j.vaccine.2014.08.02110.1016/j.vaccine.2014.08.021
- 发表时间:2014-09-292014-09-29
- 期刊:
- 影响因子:
- 作者:Md. Jasim Uddin;Tasnuva Wahed;Nirod Chandra Saha;Sheikh Shah Tanvir Kaukab;Iqbal Ansary Khan;Ashraful Islam Khan;Amit Saha;Fahima Chowdhury;John David Clemens;Firdausi QadriMd. Jasim Uddin;Tasnuva Wahed;Nirod Chandra Saha;Sheikh Shah Tanvir Kaukab;Iqbal Ansary Khan;Ashraful Islam Khan;Amit Saha;Fahima Chowdhury;John David Clemens;Firdausi Qadri
- 通讯作者:Firdausi QadriFirdausi Qadri
The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants
- DOI:10.1016/j.vaccine.2016.02.02010.1016/j.vaccine.2016.02.020
- 发表时间:2016-03-182016-03-18
- 期刊:
- 影响因子:
- 作者:Amit Saha;Arifuzzaman Khan;Umme Salma;Nusrat Jahan;Taufiqur Rahman Bhuiyan;Fahima Chowdhury;Ashraful Islam Khan;Farhana Khanam;Sundaram Muruganandham;Sreeramulu Reddy Kandukuri;Mandeep Singh Dhingra;John D. Clemens;Alejandro Cravioto;Firdausi QadriAmit Saha;Arifuzzaman Khan;Umme Salma;Nusrat Jahan;Taufiqur Rahman Bhuiyan;Fahima Chowdhury;Ashraful Islam Khan;Farhana Khanam;Sundaram Muruganandham;Sreeramulu Reddy Kandukuri;Mandeep Singh Dhingra;John D. Clemens;Alejandro Cravioto;Firdausi Qadri
- 通讯作者:Firdausi QadriFirdausi Qadri
共 2 条
- 1
Ashraful Islam Kha...的其他基金
A mobile health tool to improve antibiotic stewardship among village doctors in Bangladesh
移动医疗工具可改善孟加拉国乡村医生的抗生素管理
- 批准号:1052701610527016
- 财政年份:2022
- 资助金额:$ 18.47万$ 18.47万
- 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
An immunotherapeutic IgY formulation against norovirus diarrhea
一种针对诺如病毒腹泻的免疫治疗 IgY 制剂
- 批准号:1069353010693530
- 财政年份:2023
- 资助金额:$ 18.47万$ 18.47万
- 项目类别:
A mobile health tool to improve antibiotic stewardship among village doctors in Bangladesh
移动医疗工具可改善孟加拉国乡村医生的抗生素管理
- 批准号:1052701610527016
- 财政年份:2022
- 资助金额:$ 18.47万$ 18.47万
- 项目类别:
MEDSCAN: Mobile Enabled Diagnostics for Schistosomiasis Control Analytics
MEDSCAN:用于血吸虫病控制分析的移动诊断
- 批准号:1027994610279946
- 财政年份:2021
- 资助金额:$ 18.47万$ 18.47万
- 项目类别:
MEDSCAN: Mobile Enabled Diagnostics for Schistosomiasis Control Analytics
MEDSCAN:用于血吸虫病控制分析的移动诊断
- 批准号:1065481210654812
- 财政年份:2021
- 资助金额:$ 18.47万$ 18.47万
- 项目类别:
MEDSCAN: Mobile Enabled Diagnostics for Schistosomiasis Control Analytics
MEDSCAN:用于血吸虫病控制分析的移动诊断
- 批准号:1044834710448347
- 财政年份:2021
- 资助金额:$ 18.47万$ 18.47万
- 项目类别: